Strategies to control antibiotic resistance: Results from a survey in Italian children's hospitals by degli Atti, M. L. C. et al.
Ann Ig 2019; 31: 3-12   doi:10.7416/ai.2019.2253
1 Unit of Clinical Epidemiology, Bambino Gesù Children’s Hospital, Rome, Italy 
2
 Regional Health and Social Agency, Emilia-Romagna Region, Italy 
3 Department of Public Health and Pediatrics, University of Turin, Turin, Italy
4 Medical Direction, Bambino Gesù Children’s Hospital, Rome, Italy
*Pediatric antibiotic resistance study group:
Ospedale Pediatrico Bambino Gesù, Rome: Massimiliano Raponi, Marta Ciofi degli Atti, Laura Serino, Carmen D’Amore, 
Livia Gargiullo, Maia De Luca
Ospedale Infantile Regina Margherita - AOU Città della Salute e della Scienza, Turin: Giuliano Guareschi, Elena Migliore, 
Paola Dal Maso
Azienda Ospedaliero Universitaria Meyer, Florence: Angela Savelli, Paola Barbacci, Klaus Peter Biermann
Ospedale dei Bambini - ASST degli Spedali Civili di Brescia: Raffaele Spiazzi, Diego Amoruso, Maria Gabriela Festa, 
Daniela Strabla, Patrizia Bevilacqua, Liana Signorini
Strategies to control antibiotic resistance: results from 
a survey in Italian children’s hospitals
M.L. Ciofi degli Atti1, C. D’Amore1, C. Gagliotti2, C. Zotti3, E. Ricchizzi2,
M.L. Moro2, M. Raponi4, and the Pediatric antibiotic resistance study group* 
Key words: Antimicrobial stewardship, hospital-acquired-infections, children, survey, antibiotic 
resistance  
Parole chiave: Antimicrobial stewardship, infezioni correlate all’assistenza, bambini, indagine, 
antibiotico-resistenza
Abstract 
Background. Antimicrobial stewardship programs and comprehensive infection control programs represent 
the main strategies to limit the emergence and transmission of multi-drug resistant bacteria in hospital 
settings. The purpose of this study was to describe strategies implemented in Italian children’s hospitals 
for controlling antibiotic resistance.
Study design. Cross sectional multicenter study.
Methods. Four tertiary care Italian children’s hospitals were invited to participate in a survey aimed at 
collecting information on activities implemented as of December 2015 using a self-administered online 
questionnaire. The questionnaire was divided in three sections focalizing on: i) policies for prevention and 
control of hospital-acquired infection, ii) prevention and control of multi-drug resistant bacteria, and iii) 
antibiotic prescribing policies and Antimicrobial stewardship programs. Questionnaires were compiled 
between May and July 2016.
Results. All hospitals had multidisciplinary infection control committee, procedures on hand hygiene, 
isolation measures, disinfection/sterilization, waste disposal and prevention on infections associated to 
invasive procedures.  All sites screened patients for multi-drug resistant bacteria colonization in selected 
units, and adopted contact precautions for colonized patients. Screening during hospitalization, or in case 
of infections in the same ward were not universally implemented. All hospitals had policies on surgical 
prophylaxis, while policies on medical prophylaxis and treatment of bacterial infections varied among sites. 
Two sites recommended to review the appropriateness of antibiotic prescribing after 48-72 hours and one 
recommended de-escalation therapy. 
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Introduction
Antibiotic-resistant pathogens constitute 
an important and growing threat to public 
health (1); in fact, more than half a million 
deaths per year are estimated as attributable 
to antibiotic resistance (2). 
Inappropriate use of antibiotics is the main 
risk factor for the emergence and spread of 
multidrug resistant (MDR) microorganisms, 
particularly in the hospital setting, where 
antibiotic pressure is found at its highest 
levels (3). Antimicrobial stewardship and 
comprehensive infection control programs 
have contributed to limit the emergence 
and transmission of antimicrobial-resistant 
bacteria (4).
Antibiotics are among the drugs most 
commonly prescribed to children, and are 
often used to treat common conditions 
generally caused by viral agents, against 
which antibiotics are mostly ineffective (5). 
Several studies have reported overuse of 
broad spectrum antibiotics and excessively 
prolonged surgical antibiotic prophylaxis 
in hospitalized neonates and children (6, 
7). Recommendations for antimicrobial 
stewardship programs (ASPs) specific 
to pediatrics have been authored (8, 9) 
and several studies have shown that ASP 
programs in pediatric institutions had 
favorably affected antibiotic use (10-13).
Italy is a country with high antibiotic 
consumption and high prevalence of 
antimicrobial resistant bacteria, including 
carbapenem-resistant Enterobacteriaceae 
( C R E )  a n d  M e t h i c i l l i n - r e s i s t a n t 
Staphylococcus aureus (MRSA) (14, 15). 
Studies investigating infection control 
programs and ASPs in hospitals highlighted 
wide variations by geographical area and 
type of hospital (16-19).  Few data on actions 
implemented in children’s hospitals have 
been published up to now (20, 21). In 2014, 
the Center for Diseases Control of the Italian 
Ministry of Health funded the Project “Good 
Practices for surveillance and control of 
antibiotic-resistance” which was aimed to: a) 
identify the “best practices” for surveillance 
and control of antibiotic-resistance, and b) 
harmonize and share the collected practices 
with other contexts (22). As part of this 
national project, we conducted a survey to 
describe strategies implemented in Italian 
children’s hospital to control antibiotic 
resistance.
Methods
Study design and setting
This survey was conducted between May 
and July 2016 and involved four Italian 
children’s hospitals, i.e. Ospedale Infantile 
Regina Margherita (Turin, Piedmont), 
Ospedale dei Bambini di Brescia (Brescia, 
Lombardy), Meyer Children’s Hospital 
(Florence, Tuscany) and Bambino Gesù 
Children’s Hospital (Rome, Latium). These 
hospitals were selected to participate in the 
study because they are stand-alone tertiary 
care children’s hospitals located in Regions 
participating in the above reported national 
Project. 
Survey instrument
We developed a web-based multiple-
choice questionnaire, which explored actions 
recommended to control MDR bacteria in 
hospital settings (4, 23-27).
Conclusions. This study highlighted several areas of improvement, such as actions for screening patients in 
case of occurrence of multi-drug resistant bacteria, antimicrobial stewardship programs and implementation 
of policies targeting antibiotic prescriptions for therapeutic purposes and medical prophylaxis.
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The questionnaire included information 
on hospital characteristics and three further 
sections. The first one investigated policies 
for prevention and control of healthcare 
associated infections (HAI), including 
infection control committee, hand hygiene, 
isolation measures, disinfection and 
sterilization, waste disposal, prevention of 
infections associated with invasive procedures 
[i.e. central line-associated bloodstream 
infections (CLABSI), ventilator-associated 
pneumonia (VAP), catheter-associated 
urinary tract infections (CUTI), surgical site 
infections (SSI)], and surveillance of HAI. 
The second section concerned policies for 
prevention and control of MDR bacteria, 
including screening of CRE or MRSA 
carriers, adoption of contact precautions, 
and MRSA decolonization. The third 
section collected information on antibiotic 
prescribing policies and implementation of 
ASPs (e.g. multidisciplinary team, antibiotic 
prescription guidelines, appropriateness 
review of antibiotic prescriptions after 
48-72 hours, de-escalation therapy, pre-
authorization requirements and audit of 
antibiotic use, antibiotic consumption 
indicators).
All the collected information referred to 
the practices implemented as of December 
2015. Data were analyzed using Microsoft 
Excel 2013. 
Results 
Characteristics of respondents
Characteristics of participating hospitals 
are shown in Table 1. All hospitals had 
pediatric and neonatal intensive care, onco-
hematology and pediatric surgery units. 
The hospital total number of inpatient 
beds ranged from 214 to 607. The annual 
number of inpatients admissions and surgery 
procedures varied from 5,661 to 27,336 and 
from 2,682 to 35,192, respectively.
Policies for HAI prevention and control 
A multidisciplinary infection control 
commit tee  ( ICC) was  in  p lace  in 
all the participating sites, and always 
included an infectious disease physician, 
an epidemiologist, an infection control 
nurse and a clinical microbiologist. Other 
professionals participating to ICC varied 
by site and included pharmacists (3 sites 
out of 4), physicians from clinical wards 
(2 sites),  quality and safety managers (2 
sites), nurses from clinical wards (1 site) 
and occupational health physicians (1 site). 
ICC met quarterly in two sites, monthly in 
one site, and annually or in case of critical 
events in the remaining site.
All hospitals had policies on hand 
hygiene, isolation measures, disinfection and 
sterilization, waste disposal, prevention of 
Table 1 - Characteristics of participating children’s hospitals, 2015
Hospital 1 Hospital 2 Hospital 3 Hospital 4
Total number of beds 277 245 607 214
Number of beds by ward type
Pediatric Intensive Care Unit 10 15 30 5
Neonatal Intensive Care Unit 16 22 22 34
Neonatal pathology 175 0 15 50
Oncohematology 42 30 33 8
Surgery 48 74 187 21
Number of inpatient admissions 5,661 8,898 27,336 8,805
Number of surgical procedures 2,682 7,572 35,192 4,065
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CLABSI and SSI. Policies on prevention of 
VAP and CUTI were implemented in three 
sites (Table 2). 
Two sites conducted HAI point prevalence 
surveys annually, and one site every 
two years; the remaining site conducted 
prevalence survey of SSI every three years. 
Three sites also carried on surveillance 
of HAI incidence. HAI surveillance data 
were posted on the hospital intranet (3 
sites), or e-mailed to physicians and nurses 
responsible of wards (1 site). 
Policies for prevention and control of MDR 
bacteria
To screen for CRE or MRSA colonization, 
all hospitals performed rectal and nasal 
swabs in patients hospitalized in intensive 
care units and other high-risk units (e.g. 
transplant units, onco-hematology units), on 
admission and discharge. 
During hospitalization in these units, 
patients continued to be screened for CRE on 
a regular basis in three sites, and for MRSA in 
two sites. In case of occurrence of infections due 
to MDR, three sites had policies for screening 
all patients hospitalized in the same ward. Two 
sites performed mupirocin decolonization of 
MRSA nasal carriers (Table 3). 
All hospitals adopted contact precautions 
for patients identified as CRE or MRSA 
positive; these included antiseptic hand 
hygiene, use of gloves, gowns, single rooms 
or cohort, and dedicated patient equipment. 
Adoption of contact precautions was actively 
verified by the ICC team. In three sites, 
the adoption of contact precautions was 
notified on the patient room door and in 
clinical records. One site implemented a 
structured hand-over process to communicate 
information on contact precautions whenever 
a CRE or MRSA positive patient was 
transferred to a different ward. In two sites 
patients and their caregivers received written 
information regarding precautions to be 
adopted after discharge. 
Antibiotic prescribing policies and
implementation of antimicrobial stewardship 
programs
A multidisciplinary antimicrobial 
stewardship team was established in three 
sites (Table 4), and involved an infectious 
disease physician, an epidemiologist, a 
pharmacist and a microbiologist. Guidelines 
on antibiotic prescriptions were available 
in all sites; all hospitals implemented 
guidelines on surgical antibiotic prophylaxis, 
while implementation of recommendations 
regarding medical prophylaxis and antibiotic 
use for therapeutical purposes varied by 
hospital. 
Table 2 - Policies for HAI prevention and control by participating Hospitals, 2015
Hospital 1 Hospital 2 Hospital 3 Hospital 4
Hand Hygiene X X X X
Isolation measures X X X X
Disinfection/Sterilization X X X X
Waste disposal
(including biological waste) X X X X
CLABSI prevention X X X X
VAP prevention X X X
CUTI prevention X X X
SSI prevention X X X X
CLABSI: central line-associated bloodstream infections; VAP: ventilator-associated pneumonia; CUTI: catheter-
associated urinary tract infections: SSI: surgical site infections
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Table 3 - Policies regarding screening of carriers of CRE (A) and MRSA (B) by participating Hospitals, 2015
Hospital 1 Hospital 2 Hospital 3 Hospital 4
Screening of carriers (rectal swabs)
   at admission/discharge A/B A/B A/B A/B
Intensive Care Units A/B A/B A/B A/B
Other high risk Units* A/B A/B A/B A/B
Screening of carriers during
hospitalization
A/B A A/B
Screening of carriers in case of
occurrence of CRE infections A/B A/B A/B
Mupirocin decolonization in carriers B B
* Onco-hematology, pneumology, cardiac surgery, transplant, bone marrow transplant ward, medical and surgical 
neonatology, surgery were reported as high risk Units for CRE. Hematopoietic stem-cell transplant center, onco-
hematology, bone marrow transplant ward, cardiology were reported as high risk Units for MRSA
Table 4 - Antibiotic prescribing policies and antimicrobial stewardship programs (ASP) by participating hospitals, 
2015
Hospital 1 Hospital 2 Hospital 3 Hospital 4
ASP team X X X
Antibiotic prescription guidelines X X X X
Pneumonia X X
Urinary tract infections X X
Skin infections X
Sepsis X X
Surgical prophylaxis X X X X
Medical prophylaxis X X
Appropriateness review of antibiotic pre-
scriptions X X
Recommandations on de-escalation therapy X
Pre-authorization requirements X X X
carbapenems X X X
glycopeptides
linezolid X X
tigecycline X X
colistin
daptomycin X X
Other molecules (e.g. third generation 
cephalosporins, clindamycin.) X
Audit of antibiotic use X X X
Antibiotic prescriptions were reviewed 
after 48-72 hours in two hospitals; one 
hospital had also policies on de-escalation 
therapy. 
Formulary restriction and preauthorization 
requirements were adopted in three sites for 
specific antibiotic molecules as carbapenems 
(3 sites), linezolid, tygeciclin and daptomycin 
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(2 sites), third generation cephalosporins and 
clindamycin (1 site). Prospective audits 
of antibiotic use were conducted in three 
sites. 
Three sites out of four monitored antibiotic 
consumption. Antibiotic use was mainly 
expressed in terms of point prevalence 
of prescriptions (2 sites), use-associated 
costs (3 sites) and defined daily dose (1 
site). Days of therapy (DOT) and length-
of-therapy (LOT) had not been adopted as 
indicators of antibiotic consumption. None 
of the participating hospitals had tools for 
computer based prescribing. 
Discussion and Conclusions
Resul t s  f rom th is  survey  show 
variability in strategies to control antibiotic 
resistance in hospitalized children. Despite 
all sites participating to this study have 
multidisciplinary ICC that include essential 
professional figures (i.e. infectious disease 
specialist, hospital epidemiologist, nurse and 
clinical microbiologist) (28), pharmacists 
have been shown to be crucial to improve 
appropriateness of antibiotic prescriptions (4, 
29), but they are not universally involved in 
ICCs. Procedures on hand hygiene, isolation 
measures and disinfection/sterilization 
are available in all the participating sites, 
and all of them also monitor hand hygiene 
adherence. Methods used to collect data 
on hand hygiene adherence were not 
investigated in the present study; however, 
this issue should be further addressed since 
compliance to hand hygiene results fluctuate 
with the method used for monitoring (30). 
Data collection on susceptible profiles of 
microorganism isolated from patients admitted 
to the hospitals is important to provide timely 
antimicrobial resistance (AMR) data for 
policy decisions and to analyse temporal 
trends of AMR (15). Similarly, detection of 
CRE/MRSA carriers is crucial to implement 
contact precautions aimed at limiting in-
hospital transmission of multidrug resistant 
bacteria. According to our results, policies 
on screening of MDR carriers do also differ 
by hospital. Intensive care, onco-hematology 
and transplant units were most frequently 
considered as high-risk units for MRSA/
CRE screening, since patients are at high risk 
of serious MRSA/CRE infections and high 
proportion of MRSA/CRE infections among 
colonized patients have been documented 
(25, 31). Other differences in type of units 
considered at high risk and selected for 
routine screening of CRE/MRSA carriers 
may be due to local hospital epidemiology 
of MRSA/CRE (25, 26). 
However, all hospitals should actively 
search for carriers in a ward, whenever 
a case of CRE/MRSA occur (32). We 
also found variability in hospital policies 
concerning nasal decontamination in MRSA 
carriers (33).  Recommendation on MRSA 
decontamination were not universally shared; 
however, several national and international 
guidelines suggested to perform nasal 
decontamination of all patient MRSA-
positive (32, 34) and in particular of those 
with a higher risk of developing infections 
(25, 27, 35).
Major concern is  related to the 
implementation of antimicrobial stewardship 
programs. In particular, only 2 sites reviewed 
antibiotic therapy after 48-72 hours and 
only one had procedures focusing on de-
escalation therapy, which are recommended 
by IDSA guidelines (4). Whilst all sites have 
surgical antibiotic prophylaxis guidelines, 
the degree of variability in guidelines 
regarding medical prophylaxis and antibiotic 
treatments is substantial and could represent 
a leading factor for appropriate choice of 
antibiotic molecules, combination therapies 
and duration of administration (13, 36). 
IDSA guidelines strongly recommended 
the implementation of local antimicrobial 
guidelines since clinical pathways were 
proved to be useful for the improvement of 
several diseases management (37).
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Reliable statistics on consumption 
of antibiotics are useful to hospitals for 
performing internal assessments (such as 
consumption trends over time) and making 
comparisons with others (38). Three sites 
reported to have established metrics for the 
quantification of antibiotic consumption. 
Defined Daily Dose was used in one site 
even if this methodology is not applicable 
to the pediatric population (39); the other 
two sites monitored costs associated to 
antibiotic consumption. Metrics that are 
considered to be more specific for pediatric 
population (e.g. DOT and/or LOT) (40) 
should be implemented to obtain reliable 
data for monitoring antibiotic consumption 
in hospitalized children. To this regard, the 
use of tools for computer based prescribing 
should be promoted. 
This study has some limitations. Local 
policies were assumed to be based on 
international and national recommendations, 
though the survey did not investigate which 
were the evidence based guidelines used 
as references. Infection control activities 
and ASPs implementation may have been 
overestimated, given that data collection was 
based on self-administered questionnaire 
completed by those responsible for these 
actions (16). To this regard, results obtained 
from this survey should be complemented 
with process and outcomes indicators such 
as consumption data of alcohol-based hand 
rub, antibiotic consumption, incidence of 
HAI and infections due to MDR bacteria. 
Moreover, this study involved tertiary care 
stand alone children’s hospitals in Regions 
participating to a national project focused 
on antimicrobial resistance; thus we cannot 
assume that our results are representative 
of the policies implemented in other Italian 
hospitals taking care of children. 
In conclusion, this survey showed that 
MDR infection control policies and ASPs 
have been implemented, although areas 
of improvements have been highlighted. 
Performing such surveys over time could 
possibly help in understanding quality 
improvements and to share best practices 
among different organizations.
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Riassunto
Strategie per il controllo dell’antibiotico resistenza: 
risultati di un’indagine condotta in ospedali pedia-
trici italiani
Introduzione. I programmi di Antimicrobial Ste-
wardship e le azioni per il controllo delle infezioni ospe-
daliere rappresentano le principali strategie per limitare 
l’emergenza e la trasmissione di batteri multiresistenti 
nelle strutture ospedaliere. L’obiettivo di questo studio era 
descrivere le buone pratiche in atto negli ospedali pediatrici 
italiani per il controllo dell’antibiotico-resistenza. 
Disegno dello studio. Indagine trasversale conoscitiva 
multicentrica. 
Metodi. Quattro ospedali pediatrici italiani sono stati 
invitati a partecipare ad un’indagine conoscitiva che 
prevedeva la compilazione di un questionario on-line 
composto da tre sezioni riguardanti: i) le politiche per 
la prevenzione e il controllo delle infezioni acquisite in 
ospedale, ii) la prevenzione e controllo dei batteri mul-
tiresistenti e iii) politiche di prescrizione di antibiotici 
e Antimicrobial Stewardship. I questionari sono stati 
compilati tra maggio e luglio 2016 e facevano riferimento 
alle attività implementate nell’anno 2015.
Risultati. Tutti gli ospedali avevano istituito un 
comitato multidisciplinare per il controllo delle infe-
zioni e redatto procedure per l’igiene delle mani, le 
misure di isolamento, la disinfezione/sterilizzazione, lo 
smaltimento dei rifiuti e la prevenzione delle infezioni 
associate a procedure invasive. In tutti gli ospedali erano 
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presenti procedure per lo screening dei portatori di batteri 
multiresistenti al momento del ricovero dei pazienti in 
Unità Operative ad alto rischio. In caso di infezioni o 
colonizzazioni da batteri multiresistenti, tutti i centri 
adottavano precauzioni da contatto. L’attività di scre-
ening dei pazienti durante il ricovero in ospedale, o in 
caso di infezioni insorte nello stesso reparto di degenza, 
non era stata implementata in maniera universale. Tutti 
gli ospedali avevano adottato politiche sulla profilassi 
chirurgica, mentre la disponibilità di procedure sulla pro-
filassi medica e sul trattamento delle infezioni batteriche 
variava tra i diversi centri. In due ospedali esisteva una 
procedura per la verifica dell’appropriatezza prescrittiva 
dopo 48-72 ore e uno dei due prevedeva raccomandazioni 
sulla de-escalation therapy.
Conclusioni. Questo studio ha evidenziato diverse 
aree di miglioramento, tra cui la necessità di implemen-
tare: 1) azioni per lo screening dei pazienti in caso di 
infezioni da batteri multiresistenti nello stesso reparto 
di degenza, 2) Antimicrobial Stewardship e 3) politiche 
sulla prescrizione antibiotica per fini terapeutici e per la 
profilassi medica.
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